ey0015.8-7 | Important for Clinical Practice | ESPEYB15
D El-Maouche , CJ Hargreaves , N Sinaii , A Mallappa , P Veeraraghavan , DP Merke
ey0015.10-4 | Continuous glucose monitoring, insulin pumps and artificial pancreas | ESPEYB15
M Gimenez , AJ Tannen , M Reddy , V Moscardo , I Conget , N Oliver
ey0015.11-3 | New insight into obesity comorbidities | ESPEYB15
G Twig , A Vivante , T Bader , E Derazne , AM Tsur , M Levi , N Goldberger , A Leiba , JD Kark
ey0015.13-5 | How does paediatric endocrinology and diabetes fit in the global initiatives? | ESPEYB15
ML Wilson , KA Fleming , MA Kuti , LM Looi , N Lago , K Ru
ey0015.13-9 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
N Lascar , J Brown , H Pattison , AH Barnett , CL Bailey , S Bellary
ey0015.13-18 | Advances in the Diagnosis and Management of Congenital Hypothyroidism | ESPEYB15
L Mehran , D Khalili , S Yarahmadi , A Amouzegar , M Mojarrad , N Ajang , F Azizi
ey0015.14-12 | The ‘nocebo’ effect: psychogenic but truly harmful | ESPEYB15
A Gupta , D Thompson , A Whitehouse , T Collier , B Dahlof , N Poulter , R Collins , P Sever , Investigators ASCOT
ey0020.2-11 | Long-Acting Growth Hormone (LAGH) | ESPEYB20
A Juul , P Backeljauw , M Hojby , M Kawai , RJ Kildemoes , A Linglart , N Zuckerman-Levin , R Horikawa
ey0020.6-16 | Food for Thought | ESPEYB20
A Van't Westeinde , N Padilla , M Siqueiros Sanchez , S Fletcher-Sandersjoo , O Kampe , S Bensing , S Lajic
ey0020.12-8 | Steroids | ESPEYB20
K Sarafoglou , DP Merke , N Reisch , H Claahsen-van der Grinten , H Falhammar , RJ Auchus